Brief: Vivos Therapeutics Announces Exclusive Distribution Agreement With GM Instruments For U.S., Canada
29/06/2022 13:09
June 29 (Reuters) - Vivos Therapeutics Inc VVOS.O :
* VIVOS THERAPEUTICS ANNOUNCES EXCLUSIVE DISTRIBUTION
AGREEMENT
WITH GM INSTRUMENTS, LTD. FOR THE U.S. AND CANADA
* VIVOS THERAPEUTICS - UNDER NEW AGREEMENT, EFFECTIVELY
IMMEDIATELY, VIVOS BECOMES EXCLUSIVE U.S. AND CANADIAN
DISTRIBUTOR OF NR6 RHINOMANOMETER
Source text for Eikon: ID:nGNX5VGsvn
Further company coverage: VVOS.O
Recent news on Vivos Therapeutics
See all newsBrief: Vivos Therapeutics Closes Acquisition Of Stake In Sod Sciences And 50% Interest In Pseudohypoxia Test, Opening A Potential Path To Access More Than 325,000 New Patients Through The Aha Channel
Brief: Vivos Therapeutics - Audit Reports For Fy2025 And Fy2024 Include Substantial Doubt About Going Concern
Brief: Vivos Therapeutics And South Palm Cardiovascular Associates Sign Definitive Agreements To Launch Regional Sleep Testing And Treatment Center
Vivos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Vivos Therapeutics Q2 revenue rises 35% on service growth